RT Journal Article
SR Electronic
T1 437 Optimised achilles VELOS<sup>TM</sup> process 2b manufacturing platform generates a significant dose boost of reactive CD8 and CD4 clonal neoantigen-reactive T cells for the treatment of solid cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A486
OP A486
DO 10.1136/jitc-2023-SITC2023.0437
VO 11
IS Suppl 1
A1 Sassi, Monica
A1 Gomez, Sandro
A1 Rologi, Evi
A1 Madigan, Meghan
A1 Tang, Joanne
A1 Thirkell, Sarah
A1 Banwo, Samuel Jide
A1 Ogunleye, Temi
A1 McKeeman, Sophie
A1 Law, Claire
A1 Meyyappan, Unnaamalai
A1 Kotsiou, Eleni
A1 Newton, Katy
A1 Oakes, Theres
A1 Kosmac, Miha
A1 Goodsell, Luke
A1 Carolan, Connor
A1 Ahern, Justin
A1 Hillyer, Tim
A1 Ndlovu, Bongi
A1 Fraser, Henrieta
A1 Quezada, Sergio A
A1 Samuel, Edward
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A486.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.